Cellectar Biosciences, Inc.·4

Dec 28, 4:30 PM ET

Elefant Dov 4

4 · Cellectar Biosciences, Inc. · Filed Dec 28, 2020

Insider Transaction Report

Form 4
Period: 2020-12-28
Elefant Dov
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2020-12-28$1.35/sh+7,407$9,99911,755 total

Documents

1 file
  • 4
    tm2039438d1_4.xmlPrimary

    OWNERSHIP DOCUMENT